Competition Module
When forecasts are wrong, patient share is usually the cause. Equinox Group offers solutions, one of which is the Competition Module component of the Equinox Group forecast models that predicts the year-by-year shares of all agents in the therapeutic market as a function of key factors including competitive intensity (e.g., number of existing competitors, clinical innovation of developmental competitors).

Key Factors Affecting Patient Share in Equinox Group Forecast Models

  • The clinical advantages and disadvantages (from primary research or Equinox Share Predictor [ESP]) that the client’s agent offers (e.g., efficacy, side effects, costs)
  • The clinical advantages and disadvantages of every other agent entering the market
  • The number of existing competitors and the client agent’s level of competition with each existing competitor
  • The client agent’s level of competition with each emerging competitor
  • Time—i.e., the order of entry and duration on the market of each agent compared with all other competitors
  • The ability of a drug to be used in polypharmacy

The Competition Module allows the client to include assumptions about the success of other new competitors and the impact that those competitors will have on the patient share of the client’s agent.

[CONTACT EQUINOX]